Workflow
5月27日ETF晚报丨多只医药生物板块ETF逆市上涨；首批新型浮动费率基金今起发行
2 1 Shi Ji Jing Ji Bao Dao·2025-05-27 09:18

ETF Industry News - The three major indices experienced fluctuations and declines, with the Shanghai Composite Index down by 0.18%, the Shenzhen Component Index down by 0.61%, and the ChiNext Index down by 0.68. However, several ETFs in the pharmaceutical and biotechnology sector saw gains, including the Huatai-PB Innovation Drug ETF (517120.SH) up by 1.96%, the Innovation Drug ETF for Shanghai-Hong Kong-Shenzhen (517110.SH) up by 1.86%, and the Innovation Drug ETF for Hong Kong-Shenzhen (159622.SZ) up by 1.80% [1][4][11] - According to Everbright Securities, multiple domestic innovative drug research projects have been selected for the 2025 ASCO conference, indicating a robust trend in domestic pharmaceutical research, particularly in cancer treatment [1][4] - Minsheng Securities highlighted that the innovative drug sector is a key focus for the year, emphasizing areas such as anti-tumor, autoimmune, GLP-1, stem cell, and gene therapy, while also monitoring domestic innovation in pharmaceuticals and medical consumption, especially in the beauty sector [1][4] ETF Market Performance - As of April 2025, the total scale of ETFs in the Shanghai and Shenzhen markets exceeded 4 trillion yuan, with the Shanghai market having 680 ETFs valued at 29,625.45 billion yuan and the Shenzhen market having 467 ETFs valued at 10,947.55 billion yuan [3] - The cross-border ETFs performed the best today, with an average increase of 0.60%, while commodity ETFs had the worst performance, with an average decrease of 0.67% [9] - The top-performing ETFs today included the Huatai-PB Innovation Drug ETF (517120.SH), the Innovation Drug ETF for Shanghai-Hong Kong-Shenzhen (517110.SH), and the Innovation Drug ETF for Hong Kong-Shenzhen (159622.SZ), with respective gains of 1.96%, 1.86%, and 1.80% [11][12] Trading Volume - The top three ETFs by trading volume today were the A500 ETF (512050.SH) with 2.714 billion yuan, the A500 Index ETF (159351.SZ) with 2.466 billion yuan, and the CSI 300 ETF (510300.SH) with 2.285 billion yuan [14][15]